Previous slide
Next slide
Introduction
We are delighted to announce the highly anticipated BioPharma Medical Affairs Nexus, set to take place on the 18th and 19th of Nov 2025 in the vibrant city of New Jersey. This premier conference is dedicated to gathering the industry’s key decision makers from Large, Mid and Small-sized pharmaceutical companies, all responsible for critical areas such as Medical Affairs, Medical Operations, Medical Excellence, MSL, Medical Communications, Scientific Affairs, Field Medical, Medical Education, Clinical Investigation, Business Intelligence and Medical Science.
With its emphasis on networking and knowledge exchange, this event is an absolute must for leaders seeking to expand their professional network within the pharmaceutical industry. Attendees will have the invaluable opportunity to familiarize themselves with the latest trends and technological innovations in the dynamic and ever-evolving sector of Medical Affairs. Join us at the BioPharma Medical Affairs Nexus to forge new connections, gain insights from industry experts, and stay ahead of the curve in this essential field.
Our Worldwide Audience
Sector
Region
World Wide Leaders
Siddharth Jain, M.D
Medical Director, Global Medical Lead(Lysosomal Storage diseases)
Takeda
LinkedIn
Islam Sadek
Executive Director Global Medical Affairs, Magrolimab and Hematology pipeline
Gilead Sciences
LinkedIn
Ezinneka Imoh, PharmD
Associate Director, Scientific Communications, Medical Education & Training, Global Rare Diseases
Chiesi Group
LinkedIn
Sophia (Plichta) Wiedermann
Senior Manager, KOL Engagement and Professional Education
Novo Nordisk
LinkedIn
Benefits Of Attending The Conference
Building Meaningful Relations
Stay Current with Trends by Learning from Powerful Speakers
Connect with Influencers & in Turn, Your Target Audience
Get Fresh Ideas and Solutions for Your Business
Agenda
Day 1 - 7th May 2025
08:00 - 08:10 |
Registration
Selection of Coffee, Tea & Breakfast Pastries.
Selection of Coffee, Tea & Breakfast Pastries.
08:10 - 08:15 |
Chairperson Address
08:15 - 08:35 |
Presentation
08:35 - 09:35 |
Panel Discussion
09:35 - 11:35 |
Mid Morning Networking
10:15 - 10:45 |
Roundtable Discussion
11:35 - 11:55 |
Presentation
12:55 - 12:15 |
Presentation
12:15 - 12:35 |
Presentation
12:35 - 01:20 |
Lunch Break & Networking
01:20 - 01:40 |
Presentation
01:40 - 02:40 |
Panel Discussion
02:40 - 04:40 |
Afternoon Networking Session
03:20 - 03:50 |
Roundtable Discussion
04:40 - 05:00 |
Presentation
05:00 - 05:20 |
Presentation
05:20 - 05:25 |
Closing Remarks
Day 2 - 8th May 2025
08:00 - 08:10 |
Registration
Selection of Coffee, Tea & Breakfast Pastries.
Selection of Coffee, Tea & Breakfast Pastries.
08:10 - 08:15 |
Chairperson Address
08:15 - 08:35 |
Presentation
08:35 - 09:35 |
Panel Discussion
09:35 - 11:35 |
Mid Morning Networking
10:15 - 10:45 |
Roundtable Discussion
11:35 - 11:55 |
Presentation
12:55 - 12:15 |
Presentation
12:15 - 12:35 |
Presentation
12:35 - 01:20 |
Lunch Break & Networking
01:20 - 01:40 |
Presentation
01:40 - 02:40 |
Panel Discussion
02:40 - 04:40 |
Afternoon Networking Session
03:20 - 03:50 |
Roundtable Discussion
04:40 - 05:00 |
Presentation
05:00 - 05:20 |
Presentation
05:20 - 05:25 |
Closing Remarks
Testimonials
I must say it has been a wonderful platform for networking and the presentations were very helpful and great insights overall so I can recommend it.
It is an excellent opportunity to meet other experts and fields to interact so we had lovely discussions and very interesting presentations from new ranging technologies.
I had some nice conversations and a lot of new things and used perspectives from other people so I enjoyed being here.
I’m really very happy to be here, to be attendees of the 4th clinical trials nexus conference. It's my first time to participate and sponsor such events performed by procurement direct.
I have been giving talks to lots of different summits but I still found that there were people here that I had not met and I was able to make a very good contact with, for me this conference is very worthwhile.
I really appreciate the opportunity to have discussions with my colleagues at pharma biotech companies about their experience and handling or dealing with the problems and hope to come back next year.
I would like to share my positive feedback; six qualified leads, that's a great outcome in my evaluation.
Previous
Next
Agenda Streams
Stream 1
Medical Affairs Strategy
Stream 2
Medical Communication
Stream 3
Best Practices for MSLs
